Insurers Object To $4.8M Ferring, Aventis Antitrust Deal

Law360, New York (March 27, 2013, 5:39 PM ET) -- Aetna Inc. and other insurers on Monday told a New York federal judge they oppose the $4.75 million settlement of a proposed class action accusing Ferring BV and Aventis Pharmaceuticals Inc. of thwarting generic competition for an antidiuretic drug by fraudulently obtaining a patent for it.

Aetna, Cigna Inc., Humana Inc. and WellPoint Inc. say as a substantial part of the third-party payor settlement class, they believe the proposed settlement is untenable, and that sending out a notice of settlement that major class members object to...
To view the full article, register now.